SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-077080
Filing Date
2021-06-04
Accepted
2021-06-04 16:34:36
Documents
13
Period of Report
2021-06-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2118518d1_8k.htm   iXBRL 8-K 28965
2 EXHIBIT 10.1 tm2118518d1_ex10-1.htm EX-10.1 438910
  Complete submission text file 0001104659-21-077080.txt   754764

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ocul-20210604.xsd EX-101.SCH 3178
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocul-20210604_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocul-20210604_pre.xml EX-101.PRE 22705
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2118518d1_8k_htm.xml XML 3495
Mailing Address 24 CROSBY DRIVE BEDFORD MA 01730
Business Address 24 CROSBY DRIVE BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36554 | Film No.: 21996957
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences